Thais Freitas

Oct 16, 2023 | academic.oup.com | Su Young |Carey-Ann D |María Virginia |Thais Freitas

Pseudomonas aeruginosa is one of the most challenging nosocomial pathogens because of its intrinsic and extrinsic antimicrobial resistance capabilities, which translate to inappropriate initial antibiotic therapy.1,2 Infections caused by resistant P. aeruginosa are associated with significant morbidity and mortality necessitating improved treatment strategies.1–3 While P.